INS and Alzheimer disease: Take AD for example: it can promote Aβ aggregation and simultaneously inhibit Aβ clearance,28, 29, 30 trigger synaptic dysfunction, disrupt the blood–brain barrier, exaggerate tauopathy‐mediated neurodegeneration, and dysregulate insulin signaling.13, 31, 32